VJETNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as VTAK
Flyte Aviation, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.82−0.02 (-2.62%)
Close on Oct 19, 2026
- Market cap
- $2.26M
- P/E (TTM)
- –
- Dividend yield
- –
Flyte Aviation, Inc. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vascular [Member] | – | – | – | – | – | $259.00K | $1.28M | $1.55M | $259.00K | – | – |
| Dermatology [Member] | – | – | – | – | – | $4.15M | $5.92M | $4.71M | $5.61M | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $819.00K | $420.00K | $442.00K | – | $22.00K | $254.00K | $3.86M | $3.16M | $3.07M | 100.0% | +95.0% |
| Software Upgrade Services [Member] | $0 | $0 | $0 | – | – | – | – | – | – | 0.0% | – |
| Service and Other [Member] | – | – | – | – | – | $5.00K | $3.34M | $3.10M | $2.80M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| US [Member] | $655.00K | $278.00K | $331.00K | – | – | $4.18M | $6.57M | $5.84M | $5.27M | 80.0% | +135.6% |
| Europe [Member] | $164.00K | $142.00K | $111.00K | – | – | – | – | – | – | 20.0% | +15.5% |
| All other countries | – | – | – | – | – | $224.00K | $631.00K | $422.00K | $597.00K | – | – |
From the segment and revenue-disaggregation notes of Flyte Aviation's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.